Azashine 100 mg Injection is classified as an anti-metabolite medication, utilized in adults diagnosed with higher-risk myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia. These disorders impact the bone marrow and may lead to complications in the production of normal blood cells.
Azashine 100 mg Injection contains Azacitidine, which functions by inhibiting the growth of cancer cells. It supports the bone marrow in generating normal blood cells while eliminating abnormal cells present in the bone marrow.
Occasionally, Azashine 100 mg Injection may lead to side effects such as nausea, vomiting, diarrhoea, constipation, weakness, headache, and reactions at the injection site. Most of these side effects typically do not necessitate medical intervention and tend to resolve on their own over time. However, do not hesitate to consult your doctor if any side effects persist or worsen.
Avoid using Azashine 100 mg Injection if you are pregnant or breastfeeding. If you become pregnant during the course of treatment with Azashine 100 mg Injection, seek medical advice immediately. This medication is not advised for children, as its safety and efficacy have not been confirmed. Ensure you inform your doctor about your health status and any medications you are taking to prevent potential side effects or interactions.
